login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ABBVIE INC (ABBV) Stock News
USA
- NYSE:ABBV -
US00287Y1091
-
Common Stock
231.04
USD
-2.83 (-1.21%)
Last: 11/19/2025, 2:58:25 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ABBV Latest News, Press Relases and Analysis
All
Press Releases
19 days ago - By: Chartmill
- Mentions:
CHD
AJG
ERIE
BAX
...
Exploring the top movers within the S&P500 index during today's session.
19 days ago - By: Chartmill
- Mentions:
CHD
AJG
ERIE
DXCM
...
Discover which S&P500 stocks are making waves on Friday.
5 hours ago - By: Benzinga
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
13 hours ago - By: Zacks Investment Research
- Mentions:
AZN
JNJ
LLY
AbbVie Stock Rebounds After Q3 Dip: Time to Buy, Hold or Sell?
13 hours ago - By: Zacks Investment Research
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
a day ago - By: AbbVie
AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma
2 days ago - By: Zacks Investment Research
- Mentions:
BIIB
JNJ
Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3
2 days ago - By: Benzinga
A Look Into AbbVie Inc's Price Over Earnings
3 days ago - By: The Motley Fool
AbbVie Stock Falls 4% -- What Investors Need to Know
3 days ago - By: The Motley Fool
- Mentions:
PFE
NVO
LLY
AMGN
...
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
5 days ago - By: AbbVie
AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of Those Living with Blood Cancer
6 days ago - By: Zacks Investment Research
- Mentions:
BMY
JNJ
PFE
MRK
...
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
6 days ago - By: Zacks Investment Research
- Mentions:
AZN
IRWD
IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?
7 days ago - By: Zacks Investment Research
- Mentions:
GS
Stock Market News for Nov 13, 2025
7 days ago - By: AbbVie
AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™
7 days ago - By: Zacks Investment Research
- Mentions:
BIIB
JNJ
LLY
Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month
7 days ago - By: Stocktwits
- Mentions:
GOOG
AbbVie Reportedly Ends Partnership With Alphabet-Backed Calico Life Sciences
7 days ago - By: Zacks Investment Research
- Mentions:
JNJ
LLY
How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?
8 days ago - By: AbbVie
Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence
9 days ago - By: Zacks Investment Research
- Mentions:
AZN
IRWD
RLAY
IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars
10 days ago - By: Zacks Investment Research
- Mentions:
LLY
PFE
NVO
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs?
14 days ago - By: Stocktwits
- Mentions:
IRWD
GS
Ironwood Pharma Stock Soars After FDA Grants Approval For Irritable Bowel Syndrome Drug In Pediatric Patients
19 days ago - By: Chartmill
- Mentions:
AJG
ERIE
RMD
DXCM
...
Gapping S&P500 stocks in Friday's session
20 days ago - By: Chartmill
ABBVIE INC (NYSE:ABBV) Reports Mixed Q3 2025 Results with EPS Beat and Revenue Miss
Please enable JavaScript to continue using this application.